Genomic gain at 6p21: A new cryptic molecular rearrangement in secondary myelodysplastic syndrome and acute myeloid leukemia

Leukemia

Volumn 20, Issue 6, 2006, Pages 958-964

  La Starza, R ^a   Aventin, A ^b   Matteucci, C ^a   Crescenzi, B ^a   Romoli, S ^a   Testoni, N ^c   Pierini, V ^a   Ciolli, S ^d   Sambani, C ^e   Locasciulli, A ^f   Di Bona, E ^g   Lafage Pochitaloff, M ^h   Martelli, M F ^a   Marynen, P ⁱ   Mecucci, C ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^f SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^g San Bortolo Vicenza Hospital   (Italy)

^h INSTITUT PAOLI CALMETTES   (France)

ⁱ DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

6p rearrangements; Genomic gain; Primary and secondary myeloid malignancies

Indexed keywords

DNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV 7; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHROMOSOME 6P; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME DUPLICATION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 6; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; DNA SEQUENCE; FANCONI ANEMIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC STABILITY; HUMAN; KARYOTYPE; MALE; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; TRISOMY;

EID: 33744494284     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404208     Document Type: Article

References (40)

1. Soekarman D, von Lindern M, Daenen S, de Jong B, Fonatch C, Heinze B et al. The translocation (6;9)(p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features. Blood 1992; 79: 2990-2997.
2. Oyarzo MP, Lin P, Glassman A, Bueso-Ramos CE, Luthra R, Medeiros J. Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of FLT3 mutations. Hematopathology 2004; 122: 348-358.
3. Akasaka T, Miura I, Takahashi N, Akasaka H, Yonetani N, Ohno H et al. A recurring translocation, t(3;6)(q27;p21), in non-Hodgkin's lymphoma results in replacement of the 5′ regulatory region of BCL-6 with a novel H4 histone gene. Cancer Res 1997; 57: 7-12.
4. Chen W, Itoyama T, Chaganti RSK. Splicing factor SRP20 is a novel partner of BCL6 in a t(3;6)(q27;p21) translocation in transformed follicular lymphoma. Genes Chromosome Cancer 2001; 32: 281-284.
5. Sonoki T, Harder L, Horsman DE, Karran L, Taniguchi I, Willis TG et al. Cyclin D3 is a target of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood 2001; 98: 2837-2844.
6. Shaughnessy J, Gabrera A, Qi Y, Brents L, Zhan F, Tian E et al. Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma. Blood 2001; 98: 217-223.
7. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B et al. Deregulation of MUM/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 1997; 17: 226-230.
8. Johansson B, Mertens F, Heim S, Kristoffersson U, Mitelman F. Cytogeentics of secondary myelodysplasia (sMDS) and acute nonlymphocytic leukemia (sANLL). Eur J Haematol 1991; 47: 17-27.
9. Mecucci C, Michaux J-L, Louwagie A, Boogaerts M, Van Den Berghe H. The short arm of chromosome 6 is nonrandomly rearranged in secondary myelodysplastic syndromes. Cancer Genet Cytogenet 1988; 31: 147-155.
10. Huret JL, Schoenwald M, Brizard A, Guilhot F, Vilmer E, Tanzer J. Chromosome 6p rearrangements appear to be secondary changes in various haematological malignancies. Leukemia Res 1989; 13: 819-824.
11. Mancini M, Mecucci C, Cedrone M, Rondinelli MB, Aloe-Spiriti A, Alimena G. Unbalanced 6p translocation as primary karyotipic anomaly in secondary acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1992; 60: 93-95.
12. Jacob AK, Sreekantaiah C, Baer MR, Sandberg AA. Translocation (1;6)(p12;p23) in ANLL. Cancer Genet Cytogenet 1990; 45: 67-71.
13. Michalovà K, Lemez P, Bartsch O, Brezinova J, Zemanova Z, Jelinek J et al. Derivative (6)t(1;6)(q22;p21) revealed in bone marrow cells by FISH 9 months before diagnosis of acute T-lymphoblastic leukemia. Cancer Genet Cytogenet 1996; 86: 131-135.
14. Mathew S, Head D, Rodriguez-Galindo C, Raimondi S. Trisomy of the long arm of chromosome 1 resulting in a dicentric derivative (6)t(1;6) chromosome in a child with myelodysplastic syndrome following treatment for a primitive neuroectodermal tumor. Leukemia Lymphoma 2000; 37: 213-218.
15. Mitelman F (ed) An International System for Human Cytogenetic Nomenclature (ISCN). Basel: S Karger, 1995.
16. Crescenzi B, La Starza R, Romoli S, Beacci D, Matteucci C, Barba G et al. Submicroscopic deletions in 5q- associated malignancies. Haematologica 2004; 89: 281-285.
17. La Starza R, Specchia G, Cuneo A, Beacci D, Nozzoli C, Luciano L et al. The hypereosinophilic syndrome: Fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases. Haematologica 2005; 90: 596-601.
18. Matteucci C, La Starza R, Crescenzi B, Falzetti D, Romoli S, Emiliani C et al. Interpretation of the complex karyotype and identification of a new 6p amplicon by integrated comparative genomic hybridization and fluorescence in situ hybridization investigations on the U937-I cell line. Cancer Genet Cytogenet 2002; 135: 28-34.
19. Mauritzson N, Albin M, Rylander L, Billstrom R, Ahlgren T, Mikoczy Z et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leukemia 2002; 16: 2366-2378.
20. Sasaki MS, Tonomura A. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. Cancer Res 1973; 33: 1829-1836.
21. Cuthbert G, Thompson K, McCullough S, Watmore A, Dickinson H, Telford N et al. MLL amplification in acute leukaemia: A United Kingdom Cancer Cytogenetics Group (UKCCG) study. Leukemia 2000; 14: 1885-1891.
22. Mathew S, Lorsbach RB, Shearer P, Sandlund JT, Raimondi SC. Double minute chromosomes and c-MYC amplification in a child with secondary myelodysplastic syndrome after treatment for acute lymphoblastic leukemia. Leukemia 2000; 14: 1314-1315.
23. Bailey JA, Gu Z, Clark RA, Reinert K, Samonte RV, Schwartz S et al. Recent segmental duplications in the human genome. Science 2002; 297: 1003-1007.
24. Stankiewicz P, Lupski JR. Genome architecture, rearrangements and genomic disorders. Trends Genet 2002; 18: 74-82.
25. Ji Y, Eicher EE, Schwartz S, Nicholls RD. Structure of chromosomal duplicons and their role in mediating human genomic disorders. Genome Res 2000; 10: 597-610.
26. Saglio G, Storlazzi CT, Giugliano E, Surace C, Anelli L, Rege-Cambrin G et al. A 76 Kb duplicon maps close to the BCR gene on chromosome 22 and the ABL gene on chromosome 9: Possible involvement in the genesis of the philadelphia chromosome translocation. Proc Natl Acad Sci USA 2002; 99: 9882-9887.
27. Giglio S, Broman KW, Matsumoto N, Calvari V, Gimelli G, Neumann T et al. Olfactory receptor-gene clusters, genomic-inversion polymorphisms, and common chromosome rearrangements. Am J Hum Genet 2001; 68: 874-883.
28. Giglio S, Calvari V, gregato G, Gimelli G, Camanini S, Giorda R et al. Heterozygous submicroscopic inversions involving olfactory receptor-gene clusters mediate the recurrent t(4;8)(p16;p23) translocation. Am J Hum Genet 2002; 71: 276-285.
29. Rigaud G, Moore PS, Taruscio D, Scardoni M, Montresor M, Menestrina F et al. Alteration of chromosome arm 6p is characteristic of primary mediastinal B-cell lymphoma, as identified by genome-wide allelotyping. Genes Chromosomes Cancer 2001; 31: 191-195.
30. Lau CC, Harris CP, Lu X-Y, Perloky L, Gogineni S, Chintagumpala M et al. Frequent amplification and rearrangement of chromosomal bands 6p12p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer 2004; 39: 11-21.
31. Bjorkqvist AM, Tammilehto L, Nordling S, Nu'minen M, Anttilla S, Mattson K et al. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br J Cancer 1998; 77: 260-269.
32. Nessling M, Richter K, Schwaenen C, Roerig P, Wrobel G, Wessendorf S et al. Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. Cancer Res 2005; 65: 439-447.
33. Hauptmann S, Denkert C, Koch I, Petersen S, Scluns K, Reles A et al. Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Hum Pathol 2002; 33: 632-641.
34. Chen D, Pajovic S, Duckett A, Brown VD, Squire JA, Gallie BL. Genomic amplification in retinoblastoma narrowed to 0.6 mega-base on chromosome 6p containing a kinesin-like gene, RBKIN. Cancer Res 2002; 62: 967-971.
35. Aalto Y, Eriksson L, Seregard S, Larsson O, Knuutila S. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 2001; 42: 313-317.
36. Tchinda J, Dijkhuizen T, van der Vlies P, Kok K, Horst J. Translocations involving 6p22 in acute myeloid leukaemia at relapse: Breakpoint characterization using microarray-based comparative genomic hybridization. Br J Haematol 2004; 126: 495-500.
37. Somberger KS, Weremowicz S, Williams AJ, Quade BJ, Ligon AH, Pedeutour F et al. Expression of HMGIY in three uterine leiomyomata with complex rearrangements of chromosome 6. Cancer Genet Cytogenet 1999; 114: 9-16.
38. Giraudier S, Chagraoui H, Komura E, Barnache S, Blanchet B, LeCouedic JP et al. Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors. Blood 2002; 100: 2932-2940.
39. Andersen MK, Christiansen DH, Kirchhoff M, Pedersen-Bjergaard J. Duplication or amplification of chromosome 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents. Genes Chromosomes Cancer 2001; 31: 337-349.
40. Andersen MK, Christiansen DH, Pedersen-Bjegaard J. Amplification or duplication of chromosome band 21q22 with multiple copies of the AML1 gene and mutation of the TP53 gene in therapy-related MDS and AML. Leukemia 2005; 19: 197-200.